NCT06671834View on ClinicalTrials.gov

A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

November 21, 2025

Study Completion Date

November 21, 2025

Conditions
Acne Vulgaris
Interventions
DRUG

PF-07905428

Topical solution of PF-07905428 0.08% or PF-07905428 0.24%

DRUG

Placebo

Topical solution of placebo

Trial Locations (1)

H2X 2V1

RECRUITING

Innovaderm Research Inc., Montreal

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY